back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-19 12:23 Tx date 2025-03-17 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,150
+15,000 vol $4.01 each |
70,384 | |
| Filed 2024-05-15 11:34 Tx date 2024-05-13 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,100
+15,000 vol $3.94 each |
55,384 | |
| Filed 2023-08-23 13:02 Tx date 2023-08-22 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,000
+20,000 vol $4.70 each |
40,384 | |
| Filed 2022-12-15 15:33 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$24,170
+2,417 vol $10.00 each |
9,730 | |
| Filed 2022-12-15 15:32 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,912
+4,902 vol $10.59 each |
20,384 | |
| Filed 2021-12-10 15:05 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$23,130
+2,313 vol $10.00 each |
7,313 | |
| Filed 2021-12-10 15:04 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,497
+3,342 vol $15.11 each |
15,482 | |
| Filed 2021-05-27 11:00 Tx date 2021-05-05 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2021-05-27 10:59 Tx date 2021-05-05 |
$HLS
HLS Therapeutics Inc. |
Perry, Patricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,140 |